Among patients with ASSD-ILD there is a high frequency of recurrence. The results suggested that pyrexia of unknown origin was a risk factor for recurrence. A follow-up strategy, customized treatment, and early surveillance for high-risk patients who relapse were critical to enhancing patients' quality of life and prognosis.
Ren et al. (Wed,) studied this question.